SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Jan Klimas, Catherine-Anne Field, Walter Cullen, Clodagh SM O’Gorman, Liam G Glynn, Eamon Keenan, Jean Saunders, Gerard Bury, Colum Dunne, Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users: Cochrane Reviewa, Systematic Reviews, 2013, 2, 1, 3

    CrossRef

  2. 2
    L. THORNTON, N. MURPHY, L. JONES, J. CONNELL, S. DOOLEY, S. GAVIN, K. HUNTER, A. BRENNAN, Determination of the burden of hepatitis C virus infection in Ireland, Epidemiology and Infection, 2012, 140, 08, 1461

    CrossRef

  3. 3
    Kate Frazer, Michele Glacken, Barbara Coughlan, Anthony Staines, Leslie Daly, Hepatitis C virus infection in primary care: survey of registered nurses’ knowledge and access to information, Journal of Advanced Nursing, 2011, 67, 2
  4. 4
    Davina Swan, Jean Long, Olivia Carr, Jean Flanagan, Helena Irish, Shay Keating, Michelle Keaveney, John Lambert, P. Aiden McCormick, Susan McKiernan, John Moloney, Nicola Perry, Walter Cullen, Barriers to and Facilitators of Hepatitis C Testing, Management, and Treatment Among Current and Former Injecting Drug Users: A Qualitative Exploration, AIDS Patient Care and STDs, 2010, 24, 12, 753

    CrossRef

  5. 5
    Louise Mullen, Eamon Keenan, Joseph Barry, Jean Long, Deirdre Mulholland, Loretto Grogan, Ide Delargy, Factors predicting completion in a cohort of opiate users entering a detoxification programme, Irish Journal of Medical Science, 2010, 179, 4, 569

    CrossRef

  6. 6
    Bruno Galperim, Angelo A. Mattos, Airton T. Stein, Nuttiane C. Schneider, André Buriol, André Fonseca, Vagner Lunge, Nilo Ikuta, Hepatitis C in hemodialysis: the contribution of injection drug use, The Brazilian Journal of Infectious Diseases, 2010, 14, 4, 422

    CrossRef

  7. 7
    H. Hagan, E. R. Pouget, D. C. Des Jarlais, C. Lelutiu-Weinberger, Meta-Regression of Hepatitis C Virus Infection in Relation to Time Since Onset of Illicit Drug Injection: The Influence of Time and Place, American Journal of Epidemiology, 2008, 168, 10, 1099

    CrossRef

  8. 8
    Holly Hagan, Don C. Des Jarlais, Rebecca Stern, Corina Lelutiu-Weinberger, Roberta Scheinmann, Shiela Strauss, Peter L. Flom, HCV Synthesis Project: Preliminary analyses of HCV prevalence in relation to age and duration of injection, International Journal of Drug Policy, 2007, 18, 5, 341

    CrossRef

  9. 9
    O. Fajemirokun-Odudeyi, C. Sinha, S. Tutty, P. Pairaudeau, D. Armstrong, T. Phillips, S.W. Lindow, Pregnancy outcome in women who use opiates, European Journal of Obstetrics & Gynecology and Reproductive Biology, 2006, 126, 2, 170

    CrossRef

  10. 10
    K Abe, K Suzuki, Recent trends in transmission routes of HCV, Kanzo, 2006, 47, 2, 98

    CrossRef

  11. 11
    L. Grogan, M. Tiernan, N. Geogeghan, B. Smyth, E. Keenan, Bloodborne virus infections among drug users in Ireland: a retrospective cross-sectional survey of screening, prevalence, incidence and hepatitis B immunisation uptake, Irish Journal of Medical Science, 2005, 174, 2, 14

    CrossRef

  12. 12
    W. Cullen, M. O’Leary, D. Langton, J. Stanley, Y. Kelly, G. Bury, Guidelines for the management of hepatitis C in general practice: a semi-qualitative interview survey of GPs’ views regarding content and implementation, Irish Journal of Medical Science, 2005, 174, 3, 32

    CrossRef

  13. 13
    Mark Davis, Tim Rhodes, Beyond prevention? Injecting drug user narratives about hepatitis C, International Journal of Drug Policy, 2004, 15, 2, 123

    CrossRef

  14. 14
    Walter Cullen, Hepatitis C among drug users: consensus guidelines on management in general practice, Irish Journal of Medical Science, 2004, 173, 3, 145

    CrossRef

  15. 15
    Tim Rhodes, Mark Davis, Ali Judd, Hepatitis C and its risk management among drug injectors in London: renewing harm reduction in the context of uncertainty, Addiction, 2004, 99, 5
  16. 16
    Mark Davis, Tim Rhodes, Anthea Martin, Preventing hepatitis C: ‘Common sense’, ‘the bug’ and other perspectives from the risk narratives of people who inject drugs, Social Science & Medicine, 2004, 59, 9, 1807

    CrossRef

  17. 17
    J.R. Pallás Álvarez, A.López Sánchez, N.Fontecilla Herrera, Epidemiología de las infecciones víricas prevalentes en el medio penitenciario, SEMERGEN - Medicina de Familia, 2003, 29, 1, 4

    CrossRef

  18. 18
    W Cullen, G Bury, J Barry, FD O’Kelly, Hepatitis C infection among drug users attending general practice, Irish Journal of Medical Science, 2003, 172, 3, 123

    CrossRef

  19. 19
    M. I. Memon, M. A. Memon, Hepatitis C: an epidemiological review, Journal of Viral Hepatitis, 2002, 9, 2
  20. 20
    C. Matheï, F. Buntinx, P. Van Damme, Seroprevalence of hepatitis C markers among intravenous drug users in western European countries: a systematic review, Journal of Viral Hepatitis, 2002, 9, 3
  21. 21
    Maurice Gervin, Rita Hughes, Lindsay Bamford, Bobby P Smyth, Eamon Keenan, Heroin smoking by “chasing the dragon” in young opiate users in Ireland: stability and associations with use to “come down” off “Ecstasy”, Journal of Substance Abuse Treatment, 2001, 20, 4, 297

    CrossRef

  22. 22
    C. M. Healy, M. T. Cafferkey, A. Conroy, S. Dooley, W. W. Hall, M. Beckett, R. Mackey, T. A. Clarke, M. J. White, W. A. Gorman, K. M. Butler, Hepatitis C infection in an Irish antenatal population, Irish Journal of Medical Science, 2000, 169, 3, 180

    CrossRef

  23. 23
    Alijudd Matthew Hickman, Adrian Renton, Gerry Stimson, Hepatitis C Virus Infection Among Injecting Drug Users: Has Harm Reduction Worked?, Addiction Research & Theory, 1999, 7, 1, 1

    CrossRef